Protective effect of methotrexate on lung function and mortality in rheumatoid arthritis-related interstitial lung disease: a retrospective cohort study.
Kangjoon KimAla WooYoungmok ParkSeung Hyun YongSu Hwan LeeSang Hoon LeeAh Young LeemSong Yee KimKyung Soo ChungEun Young KimJi Ye JungYoung Ae KangYoung Sam KimMoo Suk ParkPublished in: Therapeutic advances in respiratory disease (2022)
We identified risk and protective factors for lung function decline and mortality in patients with RA-ILD. MTX use was associated with favorable outcome in terms of both lung function and mortality in our cohort.
Keyphrases
- lung function
- interstitial lung disease
- rheumatoid arthritis
- systemic sclerosis
- cystic fibrosis
- chronic obstructive pulmonary disease
- air pollution
- cardiovascular events
- idiopathic pulmonary fibrosis
- disease activity
- risk factors
- high dose
- cardiovascular disease
- coronary artery disease
- type diabetes
- ankylosing spondylitis